Trevi Therapeutics Statistics Share Statistics Trevi Therapeutics has 121.78M
shares outstanding. The number of shares has increased by 36.27%
in one year.
Shares Outstanding 121.78M Shares Change (YoY) 36.27% Shares Change (QoQ) 2.21% Owned by Institutions (%) 82.62% Shares Floating 90.63M Failed to Deliver (FTD) Shares 1,220 FTD / Avg. Volume 0.05%
Short Selling Information The latest short interest is 12.09M, so 9.93% of the outstanding
shares have been sold short.
Short Interest 12.09M Short % of Shares Out 9.93% Short % of Float 11.51% Short Ratio (days to cover) 3.37
Valuation Ratios The PE ratio is -8.69 and the forward
PE ratio is -19.12.
Trevi Therapeutics's PEG ratio is
-0.14.
PE Ratio -8.69 Forward PE -19.12 PS Ratio 0 Forward PS 1096 PB Ratio 4.18 P/FCF Ratio -10.87 PEG Ratio -0.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Trevi Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.41,
with a Debt / Equity ratio of 0.01.
Current Ratio 10.41 Quick Ratio 10.41 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage -12881
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.55M Employee Count 31 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -30K Effective Tax Rate 0.06%
Stock Price Statistics The stock price has increased by 227.15% in the
last 52 weeks. The beta is 0.74, so Trevi Therapeutics's
price volatility has been higher than the market average.
Beta 0.74 52-Week Price Change 227.15% 50-Day Moving Average 7.93 200-Day Moving Average 6.13 Relative Strength Index (RSI) 69.26 Average Volume (20 Days) 2,229,622
Income Statement
Revenue n/a Gross Profit -147K Operating Income -51.52M Net Income -47.91M EBITDA -47.79M EBIT -47.94M Earnings Per Share (EPS) -0.47
Full Income Statement Balance Sheet The company has 34.1M in cash and 1.03M in
debt, giving a net cash position of 33.06M.
Cash & Cash Equivalents 34.1M Total Debt 1.03M Net Cash 33.06M Retained Earnings -287.05M Total Assets 208.34M Working Capital 197.99M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -38.26M
and capital expenditures -35K, giving a free cash flow of -38.29M.
Operating Cash Flow -38.26M Capital Expenditures -35K Free Cash Flow -38.29M FCF Per Share -0.38
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
